Research News

Recent News

NRG Oncology Research at the ASCO 2020 American Society of Clinical Oncology (ASCO) Virtual Meeting

Read More

TMIST Trial Enrollment Reaches 25,000 Patient Milestone

Read More

Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer

Read More

NRG Oncology Trial Shows Hippocampal Avoidance During Whole-Brain Radiotherapy for Brain Metastases Reduces Risks of Cognitive Toxicity and Neurologic Symptoms

Read More

ACR CRI Celebrates Opening of New Office

Read More

TMIST Trial Enrollment Reaches 20,000 – Sites Double in 2019

Read More

TMIST Trial Gains Ground on Site and Patient Milestones

Read More

ABT-414 Shows no Overall Survival Benefit for Patients with Newly Diagnosed Glioblastoma

Read More

ACR, BCRF and GE Healthcare Launch CMIST Trial

Read More

TMIST Trial Gains Steam – Opportunities Remain

Read More

NRG Oncology research featured at ASTRO 2019

Read More

Landmark Breast DBT Trial Seeks More Study Sites

Read More

ACR Data Science Institute™ Hosts International Field of AI Experts

On Sept. 25, the ACR Data Science Institute hosted an international group of leading artificial intelligence experts, researchers, medical device vendors and physicians.
Read More

CT Scans in U.S. Do Not Use More Radiation Than in Other Nations

Dose Index Registry Study Published in Radiology.
Read More

NRG-RTOG 9601 Landmark Study to Change Standard of Care for Men With Recurrent Prostate Cancer

Daily bicalutamide during and for 24 months after salvage radiation therapy improved long-term survival for men with persistent or recurrent cancer following radical prostatectomy.
Read More